药剂师在支持抑郁症患者方面的潜在作用--基于文献的观点。

IF 2.1 Q3 PHARMACOLOGY & PHARMACY
Integrated Pharmacy Research and Practice Pub Date : 2020-02-26 eCollection Date: 2020-01-01 DOI:10.2147/IPRP.S239672
Maria Kamusheva, Desislava Ignatova, Anna Golda, Agnieszka Skowron
{"title":"药剂师在支持抑郁症患者方面的潜在作用--基于文献的观点。","authors":"Maria Kamusheva, Desislava Ignatova, Anna Golda, Agnieszka Skowron","doi":"10.2147/IPRP.S239672","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The current article is aimed at identifying the best practice for counseling around depression in community and outpatient pharmacies, resulting in a draft guideline, proposing key steps and an algorithm for integration of community pharmacists into care for patients with depression.</p><p><strong>Methods: </strong>A literature review was performed followed by a detailed analysis, for the purpose of creation a short draft document used as a basis for creation of a guideline for pharmaceutical care for patients with depression. The technological scheme PRISMA flow diagram was applied. The paper is based on current knowledge, taking into consideration already published articles, guidelines, and recommendations about pharmaceutical care for patients with depression, giving a basis for further studies.</p><p><strong>Results: </strong>This paper includes two main sections: 1) depression - a short description of the main symptoms, risk factors and pharmacotherapy guidelines available in Bulgaria important for the purposes of ensuring qualitative community-based pharmaceutical care; and 2) the pharmacists' role in providing high-quality care - the main aspects of pharmaceutical care for patients with depression with specific examples.</p><p><strong>Conclusion: </strong>The involvement of pharmacists in supporting depressive patients is crucial taking into account the specific characteristics of the pharmacological treatment: delayed onset of clinical results, risks in case of sudden pharmacotherapy abruption without physician consultation, multiple adverse drug reactions and drug-drug, drug-food and drug-alcohol interactions, etc. The current article could also be used as an initial document for creating a methodological guideline for providing pharmaceutical care services for patients with depression.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"9 ","pages":"49-63"},"PeriodicalIF":2.1000,"publicationDate":"2020-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/05/16/iprp-9-49.PMC7049755.pdf","citationCount":"0","resultStr":"{\"title\":\"The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View.\",\"authors\":\"Maria Kamusheva, Desislava Ignatova, Anna Golda, Agnieszka Skowron\",\"doi\":\"10.2147/IPRP.S239672\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The current article is aimed at identifying the best practice for counseling around depression in community and outpatient pharmacies, resulting in a draft guideline, proposing key steps and an algorithm for integration of community pharmacists into care for patients with depression.</p><p><strong>Methods: </strong>A literature review was performed followed by a detailed analysis, for the purpose of creation a short draft document used as a basis for creation of a guideline for pharmaceutical care for patients with depression. The technological scheme PRISMA flow diagram was applied. The paper is based on current knowledge, taking into consideration already published articles, guidelines, and recommendations about pharmaceutical care for patients with depression, giving a basis for further studies.</p><p><strong>Results: </strong>This paper includes two main sections: 1) depression - a short description of the main symptoms, risk factors and pharmacotherapy guidelines available in Bulgaria important for the purposes of ensuring qualitative community-based pharmaceutical care; and 2) the pharmacists' role in providing high-quality care - the main aspects of pharmaceutical care for patients with depression with specific examples.</p><p><strong>Conclusion: </strong>The involvement of pharmacists in supporting depressive patients is crucial taking into account the specific characteristics of the pharmacological treatment: delayed onset of clinical results, risks in case of sudden pharmacotherapy abruption without physician consultation, multiple adverse drug reactions and drug-drug, drug-food and drug-alcohol interactions, etc. The current article could also be used as an initial document for creating a methodological guideline for providing pharmaceutical care services for patients with depression.</p>\",\"PeriodicalId\":45655,\"journal\":{\"name\":\"Integrated Pharmacy Research and Practice\",\"volume\":\"9 \",\"pages\":\"49-63\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2020-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/05/16/iprp-9-49.PMC7049755.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Integrated Pharmacy Research and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/IPRP.S239672\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrated Pharmacy Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IPRP.S239672","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本文旨在确定社区和门诊药房围绕抑郁症提供咨询服务的最佳做法,并据此起草一份指南草案,提出将社区药剂师纳入抑郁症患者护理的关键步骤和算法:方法:先进行文献综述,再进行详细分析,目的是编写一份简短的文件草案,作为编写抑郁症患者药物治疗指南的基础。采用了 PRISMA 流程图技术方案。本文以现有知识为基础,考虑了已发表的文章、指南和有关抑郁症患者药物护理的建议,为进一步研究提供了依据:本文包括两个主要部分:1)抑郁症--简述主要症状、风险因素和保加利亚现有的药物治疗指南,这对确保高质量的社区药物护理非常重要;2)药剂师在提供高质量护理中的作用--为抑郁症患者提供药物护理的主要方面,并附有具体实例:考虑到药物治疗的特殊性,药剂师参与对抑郁症患者的支持是至关重要的:临床效果的延迟显现、未经医生会诊而突然中断药物治疗的风险、多种药物不良反应以及药物与药物、药物与食物和药物与酒精之间的相互作用等。本文也可作为为抑郁症患者提供药物治疗服务的方法指南的初始文件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View.

The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View.

The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View.

The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View.

Objective: The current article is aimed at identifying the best practice for counseling around depression in community and outpatient pharmacies, resulting in a draft guideline, proposing key steps and an algorithm for integration of community pharmacists into care for patients with depression.

Methods: A literature review was performed followed by a detailed analysis, for the purpose of creation a short draft document used as a basis for creation of a guideline for pharmaceutical care for patients with depression. The technological scheme PRISMA flow diagram was applied. The paper is based on current knowledge, taking into consideration already published articles, guidelines, and recommendations about pharmaceutical care for patients with depression, giving a basis for further studies.

Results: This paper includes two main sections: 1) depression - a short description of the main symptoms, risk factors and pharmacotherapy guidelines available in Bulgaria important for the purposes of ensuring qualitative community-based pharmaceutical care; and 2) the pharmacists' role in providing high-quality care - the main aspects of pharmaceutical care for patients with depression with specific examples.

Conclusion: The involvement of pharmacists in supporting depressive patients is crucial taking into account the specific characteristics of the pharmacological treatment: delayed onset of clinical results, risks in case of sudden pharmacotherapy abruption without physician consultation, multiple adverse drug reactions and drug-drug, drug-food and drug-alcohol interactions, etc. The current article could also be used as an initial document for creating a methodological guideline for providing pharmaceutical care services for patients with depression.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
3.40%
发文量
29
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信